Dialogue Health Technologies Inc.
DLHTF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 28% | 90.1% | 254.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 49.7% | 42.3% | 40.2% | 54.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -24.5% | -366.2% | -48.4% | -108.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -29.8% | -369.4% | -56.5% | -119.4% |
| EPS Diluted | -0.39 | -4.48 | -0.31 | -0.19 |
| % Growth | 91.3% | -1,345.2% | -63.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |